BRPI0416285A - beta-lactams para o tratamento de distúrbios do snc - Google Patents
beta-lactams para o tratamento de distúrbios do sncInfo
- Publication number
- BRPI0416285A BRPI0416285A BRPI0416285-4A BRPI0416285A BRPI0416285A BR PI0416285 A BRPI0416285 A BR PI0416285A BR PI0416285 A BRPI0416285 A BR PI0416285A BR PI0416285 A BRPI0416285 A BR PI0416285A
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- cyano
- hydroxy
- halogen
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
"BETA-LACTAMS PARA O TRATAMENTO DE DISTúRBIOS DO SNC". A presente invenção relaciona-se aos novos compostos de fórmula (I), na qual ---- representa uma ligação simples ou uma dupla; R representa um radical selecionado a partir das fórmulas i) ii) iii) e iv) , nas quais R~ 1~ é halogênio, ciano, alquila de C~ 1-4~, alcóxi de C~ 1-4~, trifluormetila ou trifluormetóxi e p é zero ou um número inteiro de 1 a 3; R~ 2~ representa hidrogênio ou alquila de C~ 1-4~; R~ 3~ representa hidrogênio, hidróxi ou alquila de C~ 1-4~; R~ 4~ representa hidrogênio ou R~ 4~ juntamente com R~ 3~ representa =O ou =CH~ 2~; R~ 5~ representa fenila, naftila, um grupo heterocíclico bicíclico fundido de 9 a 10 elementos ou um grupo heteroarila de 5 ou 6 elementos, em que os ditos grupos são opcionalmente substituídos por 1 a 3 grupos independentemente selecionados a partir de trifluormetila, alquila de C~ 1-4~, hidróxi, ciano, alcóxi de C~ 1-4~, trifluormetóxi, halogênio ou S (O) q alquila de C~ 1-4~; R~ 6~ e R~ 7~ independentemente representam hidrogênio, ciano, alquila de C~ 1-4~; R~ 8~ é (CH~ 2~) rR~ 10~; R~ 9~ representa hidrogênio, halogênio, cicloalquila de C~ 3-7~, hidróxi, nitro, ciano ou alquila de C~ 1-4~ opcionalmente substituída por um ou dois grupos selecionados a partir de halogênio, ciano, hidróxi ou alcóxi de C~ 1-4~; R~ 10~ representa hidrogênio ou cicloalquila de C~ 3-7~; n representa 1 ou 2; q é 0, 1 ou 2; r é 0 ou um número inteiro de 1 a 4; ou um sal farmaceuticamente aceitável ou um solvato dos mesmos, ao processo para a sua preparação e ao seu uso no tratamento de condições mediadas por taquicininas e/ou por inibição seletiva da proteína transportadora de recaptação de serotonina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0326407.4A GB0326407D0 (en) | 2003-11-12 | 2003-11-12 | Chemical compounds |
| PCT/EP2004/012772 WO2005049600A1 (en) | 2003-11-12 | 2004-11-10 | Beta-lactams for treatment of cns disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0416285A true BRPI0416285A (pt) | 2007-01-23 |
Family
ID=29726427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0416285-4A BRPI0416285A (pt) | 2003-11-12 | 2004-11-10 | beta-lactams para o tratamento de distúrbios do snc |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US20080262041A1 (pt) |
| EP (1) | EP1689737B1 (pt) |
| JP (1) | JP2007510692A (pt) |
| KR (1) | KR20060118477A (pt) |
| CN (1) | CN1878764A (pt) |
| AR (1) | AR046233A1 (pt) |
| AT (1) | ATE401321T1 (pt) |
| AU (1) | AU2004291296B2 (pt) |
| BR (1) | BRPI0416285A (pt) |
| CA (1) | CA2546007A1 (pt) |
| CY (1) | CY1108404T1 (pt) |
| DE (1) | DE602004015144D1 (pt) |
| DK (1) | DK1689737T3 (pt) |
| ES (1) | ES2310295T3 (pt) |
| GB (1) | GB0326407D0 (pt) |
| HK (1) | HK1094698A1 (pt) |
| HR (1) | HRP20080501T3 (pt) |
| IL (1) | IL175279A0 (pt) |
| IS (1) | IS8477A (pt) |
| MA (1) | MA28156A1 (pt) |
| MY (1) | MY138378A (pt) |
| NO (1) | NO20062661L (pt) |
| PL (1) | PL1689737T3 (pt) |
| PT (1) | PT1689737E (pt) |
| RU (1) | RU2006120417A (pt) |
| SI (1) | SI1689737T1 (pt) |
| TW (1) | TW200528439A (pt) |
| WO (1) | WO2005049600A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2008009444A (es) * | 2006-01-24 | 2008-10-20 | Biosignal Ltd | Nuevas lactamas. |
| AU2015200142B2 (en) * | 2006-01-24 | 2016-07-07 | Unilever Plc | Novel lactams |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL262366A (pt) * | 1960-03-14 | |||
| FR2676055B1 (fr) * | 1991-05-03 | 1993-09-03 | Sanofi Elf | Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| CA2083891A1 (en) * | 1991-12-03 | 1993-06-04 | Angus Murray Macleod | Heterocyclic compounds, compositions containing them and their use in therapy |
| GB9200535D0 (en) * | 1992-01-10 | 1992-02-26 | Fujisawa Pharmaceutical Co | New compound |
| US5824690A (en) * | 1993-05-06 | 1998-10-20 | Hoechst Marion Roussel Inc. | Substituted pyrrolidin-3-yl-alkyl-piperidines |
| GB9317104D0 (en) * | 1993-08-17 | 1993-09-29 | Zeneca Ltd | Therapeutic heterocycles |
| GB9322643D0 (en) * | 1993-11-03 | 1993-12-22 | Zeneca Ltd | Lactam derivatives |
| HU221434B (en) * | 1994-08-25 | 2002-10-28 | Merrell Pharma Inc | Substituted piperidines, pharmaceutical compositions containing them and their use |
| US5780466A (en) * | 1995-01-30 | 1998-07-14 | Sanofi | Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present |
| TW332201B (en) * | 1995-04-06 | 1998-05-21 | Janssen Pharmaceutica Nv | 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives |
| US6211199B1 (en) * | 1995-11-17 | 2001-04-03 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| FR2779429B1 (fr) * | 1998-06-03 | 2000-07-13 | Synthelabo | Derives d'oxindole, leurs preparations et leurs applications en therapeutique |
| US6204265B1 (en) * | 1998-12-23 | 2001-03-20 | Schering Corporation | Substituted oximes and hydrazones as neurokinin antagonists |
| GB0114867D0 (en) * | 2001-06-18 | 2001-08-08 | Merck Sharp & Dohme | Therapeutic agents |
| GB0412865D0 (en) * | 2004-06-09 | 2004-07-14 | Glaxo Group Ltd | Chemical compounds |
-
2003
- 2003-11-12 GB GBGB0326407.4A patent/GB0326407D0/en not_active Ceased
-
2004
- 2004-11-10 EP EP04797809A patent/EP1689737B1/en active Active
- 2004-11-10 DE DE602004015144T patent/DE602004015144D1/de active Active
- 2004-11-10 BR BRPI0416285-4A patent/BRPI0416285A/pt not_active IP Right Cessation
- 2004-11-10 AT AT04797809T patent/ATE401321T1/de active
- 2004-11-10 KR KR1020067009274A patent/KR20060118477A/ko active IP Right Grant
- 2004-11-10 US US10/595,662 patent/US20080262041A1/en not_active Abandoned
- 2004-11-10 PL PL04797809T patent/PL1689737T3/pl unknown
- 2004-11-10 TW TW093134192A patent/TW200528439A/zh unknown
- 2004-11-10 AR ARP040104145A patent/AR046233A1/es not_active Application Discontinuation
- 2004-11-10 AU AU2004291296A patent/AU2004291296B2/en not_active Ceased
- 2004-11-10 CN CNA2004800333979A patent/CN1878764A/zh active Pending
- 2004-11-10 SI SI200430872T patent/SI1689737T1/sl unknown
- 2004-11-10 CA CA002546007A patent/CA2546007A1/en not_active Abandoned
- 2004-11-10 ES ES04797809T patent/ES2310295T3/es active Active
- 2004-11-10 DK DK04797809T patent/DK1689737T3/da active
- 2004-11-10 WO PCT/EP2004/012772 patent/WO2005049600A1/en active IP Right Grant
- 2004-11-10 RU RU2006120417/04A patent/RU2006120417A/ru not_active Application Discontinuation
- 2004-11-10 MY MYPI20044708A patent/MY138378A/en unknown
- 2004-11-10 PT PT04797809T patent/PT1689737E/pt unknown
- 2004-11-10 JP JP2006538791A patent/JP2007510692A/ja active Pending
-
2006
- 2006-04-27 IL IL175279A patent/IL175279A0/en unknown
- 2006-05-11 MA MA29020A patent/MA28156A1/fr unknown
- 2006-05-22 IS IS8477A patent/IS8477A/is unknown
- 2006-06-09 NO NO20062661A patent/NO20062661L/no not_active Application Discontinuation
-
2007
- 2007-01-24 HK HK07100589A patent/HK1094698A1/xx not_active IP Right Cessation
-
2008
- 2008-10-08 CY CY20081101120T patent/CY1108404T1/el unknown
- 2008-10-09 HR HR20080501T patent/HRP20080501T3/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1689737B1 (en) | 2008-07-16 |
| MY138378A (en) | 2009-05-29 |
| IS8477A (is) | 2006-05-22 |
| NO20062661L (no) | 2006-06-09 |
| DE602004015144D1 (de) | 2008-08-28 |
| TW200528439A (en) | 2005-09-01 |
| US20080262041A1 (en) | 2008-10-23 |
| SI1689737T1 (sl) | 2008-12-31 |
| ATE401321T1 (de) | 2008-08-15 |
| AU2004291296A1 (en) | 2005-06-02 |
| WO2005049600A1 (en) | 2005-06-02 |
| HRP20080501T3 (en) | 2008-11-30 |
| CY1108404T1 (el) | 2014-02-12 |
| KR20060118477A (ko) | 2006-11-23 |
| IL175279A0 (en) | 2006-09-05 |
| EP1689737A1 (en) | 2006-08-16 |
| PT1689737E (pt) | 2008-10-24 |
| PL1689737T3 (pl) | 2008-12-31 |
| CN1878764A (zh) | 2006-12-13 |
| AU2004291296B2 (en) | 2011-04-07 |
| MA28156A1 (fr) | 2006-09-01 |
| AR046233A1 (es) | 2005-11-30 |
| HK1094698A1 (en) | 2007-04-04 |
| JP2007510692A (ja) | 2007-04-26 |
| CA2546007A1 (en) | 2005-06-02 |
| ES2310295T3 (es) | 2009-01-01 |
| DK1689737T3 (da) | 2008-10-27 |
| GB0326407D0 (en) | 2003-12-17 |
| RU2006120417A (ru) | 2007-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0409110A (pt) | derivados de 4-(4-heterociclilalcoxi)fenil-1-(heterociclil-carboni l)piridina e compostos relacionados como antagonistas de histamina h3 para o tratamento de doenças neurológicas tais como alzheimer | |
| BRPI0510623A (pt) | compostos de derivados de prolina e morfolina | |
| EA200500342A1 (ru) | Гетероциклические замещённые пиперазины для лечения шизофрении | |
| BR9911182A (pt) | Composto, uso do mesmo, processo para o tratamento de um mamìfero, incluindo homem, de condições suscetìveis de melhora por um agonista de beta-adrenorreceptor atìpico, composição farmacêutica, e, processo para a preparação de um composto. | |
| BRPI0414450A (pt) | derivados de diazabicicloalcano substituìdos como ligandos nos receptores de alfa 7 acetilcolina nicotìnica | |
| BR0201697A (pt) | Compostos de alfa-aminoácid0, processo para a sua preparação e composições farmacêuticas contendo os mesmos | |
| AR045595A1 (es) | Composiciones utiles como inhibidores de proteinas quinasas | |
| BR0207996A (pt) | Composto, método de controle de pragas invertebradas e composição para controle das mesmas | |
| BR9914696A (pt) | Composto, processo para tratamento de distúrbio mediado por ciclo-oxigenase-2 em um indivìduo, e, composição farmacêutica | |
| BR9912109A (pt) | Compostos, composições farmacêuticas, processo para a manufatura de um composto, e, método de tratar um mamìfero sofrendo de inflamação patológica e autoimunidade | |
| ATE108774T1 (de) | Isoindolonderivate, ihre herstellung und ihre verwendung als zwischenprodukte zur herstellung von substanz-p-antagonisten. | |
| BR0205602A (pt) | EnantiÈmero possuindo a configuração s na posição-4 dos seu anel pirazol de um composto, composição farmacêutica, método para a preparação de composições farmacêuticas, processo para a preparação de compostos, e, métodos de tratamento de distúrbios que envolvem neurotransmissão canabinóide | |
| BR0110112A (pt) | Derivados de pirrolidina e piperidina e seu uso para o tratamento de distúrbios neurodegenerativos | |
| BRPI9913542B8 (pt) | derivados de dihidrobenzodioxina carboxamida e dihidrobenzodioxina cetona como antagonistas do receptor 5-ht4 bem como composição farmacêutica, processo para a preparação dos referidos derivados e uso dos mesmos | |
| KR890002121A (ko) | 신규 벤조피란 유도체, 그의 제조방법 및 이를 함유하는 제약학적 조성물 | |
| UY26048A1 (es) | Derivados de piridopiranoacepinas, su preparacion y su aplicacion terapeutica | |
| EA200401025A1 (ru) | Полиморфы клопидогреля и их применение в качестве антитромботических соединений | |
| AR008291A1 (es) | Derivados de tetrahidroisoquinolina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y su uso para la preparacionde un medicamento. | |
| RU94023250A (ru) | 2,3-дигидро-1,4-бензодиоксин-5-ил-пиперазиновые производные, обладающие 5-нт1а-антагонистической активностью, способы их получения, фармкомпозиция на их основе, получение ее и способ лечения расстройств нервной системы | |
| BRPI0406500A (pt) | processo farmacêutico e compostos preparados pelo mesmo | |
| BR0215200A (pt) | Pirrolidina-2-onas como inibidores de fator xa | |
| BR9916669A (pt) | Uso de derivados de ácidos 4-biarilbutìricos e 5-biarilpentanóicos substituìdos como inibidores de metaloproteases de matriz para o tratamento de doenças respiratórias | |
| SE8107387L (sv) | Nya fenylalkylaminer, framstellning derav och anvendning som lekemedel | |
| BRPI0501769A (pt) | Compostos de pirrolidina e tiazolidina, processo para sua preparação e composições farmacêuticas contendo os mesmos | |
| BRPI0416285A (pt) | beta-lactams para o tratamento de distúrbios do snc |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014. |